HEALTH● LOWSep 1 · Sep 1, 2026, 4:45 AM
Eli Lilly diabetes drug Mounjaro approved to reduce cardiovascular risks
businesstoday.in · India · global
The diabetes drug Mounjaro, developed by Eli Lilly, has been approved for its ability to reduce cardiovascular risks. This represents a significant advancement in treating diabetes and related heart conditions.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More from India
CONFLICT2h agoIndia, Pakistan summon each other’s diplomats after naval ships collide in Arabian SeaSouth China Morning PostBUSINESS2h agoInside India newsletter: The world’s largest real-time payments system will no longer be free for allCNBCPOLITICS4h agoUS Congress passes bill targeting Russia’s leading energy buyers – China and IndiaSouth China Morning PostPOLITICS5h agoTrump lauds India's crackdown on poppy farming; lists 23 major drug transit nationsThe Hindu
More in Health
HEALTH2h agoPsychology says that acquiring your father's bad habits despite having sworn you wouldn't is not a lack of willpower: they were installed before you could speak, and most men spend forty years fighting against them before finally understanding themClarínHEALTH3h agoCompanies illegally selling unapproved Eli Lily weight loss drug Retatrutide onlineCBS NewsHEALTH4h agoHere's why an Arizona medical examiner is working to track heat-related deathsNPR NewsHEALTH6h agoTexas Abortion Ban Blamed in Pregnant Woman’s Death in LawsuitNYT US